Home › Open-Angle Glaucoma › NCT06933836

DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

How Does First Line Treatment With DSLT Perform in Treatment-naïve Patients With Newly Diagnosed Primary Open Angle Glaucoma

Who can join

Ages 30 and older · All sexes

Inclusion Criteria:

* Primary open angle glaucoma
* Patients age 30 or greater with an IOP of 18-26 mmHg
* Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines)
* DSLT procedure

Exclusion Criteria:

* History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery
* Angle closure patients
* Ocular Hypertension
* Baseline VF MD of worse than -12dB
* Uncontrolled systemic microvascular disease (eg. HTN, DM)
* Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)

About the study

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

What is being tested

• DSLT enables newly diagnosed patients to remain well controlled and off medications (device)

Sponsor: Barnet Dulaney Perkins Eye Centers · Participants: 55 · Started: Mar 31, 2025

Contact the study team

• Derek J Arnson, Master of Education · Phone: 4804201005
• Christine Funke, Medical Doctor · Phone: 4804201005

Official record on ClinicalTrials.gov — NCT06933836

Locations in the U.S.

Conditions

• Open-Angle Glaucoma
• Glaucoma

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.